Advanced Gene & Cell Technologies (AGCT) , a resident startup of the Skolkovo Foundation’s biomed cluster, has received the first tranche of investment from the RBV Capital venture fund allocated to carry out Russia’s first clinical practice...
Infectex , a resident of the Skolkovo Foundation’s biomed cluster, has completed clinical trials in Russia of its new drug for treating TB, the company announced on Friday, World Tuberculosis Day. The drug – SQ109 – has demonstrated high...
The Skolkovo Foundation has signed a cooperation agreement with BioCubaFarma, Cuba’s biggest biotech company, continuing a series of agreements and mutual visits between the foundation and the island nation. Prime Minister Dmitry Medvedev, right...
Finland’s BioCity Technopark is to build a biotech technopark at the Skolkovo innovation centre under an agreement signed Tuesday at the ongoing International Association of Science Parks and Areas of Innovation (IASP) conference in Moscow. Kirill...
В Инновационном Центре «Сколково» будет построен биотехнологического технопарк BioCity Technopark. Соответствующее соглашение подписали на проходящей в Москве конференции IASP 2016 вице-президент Фонда «Сколково», исполнительный директор...
As nations across the globe marked World Cancer Day on February 4, the Skolkovo Foundation announced the creation of a new Cancer Centre of Excellence. The new centre is set to coordinate the work of all the startup companies and partners currently working...
Компания «3Д Биопринтинг Солюшенс» (резидент кластера биомедицинских технологий Фонда «Сколково») объявила об успешном завершении уникального эксперимента по печати органного конструкта щитовидной железы мыши. Конструкт не отторгается...